< Back to latest news & events

Event

IP in Healthcare Conference 2020

March 2020

Event date: 3rd March 2020

March 2020 in London and Manchester. HGF’s sixth annual Healthcare Conference reviews the latest intellectual property issues in the pharmaceuticals, life sciences and medical devices sectors.

Update

It is with great regret that we have taken the decision to cancel the HGF IP in Healthcare conference in London on Thursday 12th March. This is a precautionary measure by the firm based on current situation surrounding the Coronavirus in the UK and Europe.

We would like to take this opportunity to thank you for reserving your place and we look forward to welcoming you again in 2021.

Dates

The Conference will take place on the following dates:

  • Tuesday 3rd March in Alderley Park, Manchester
  • Thursday 12th March in Barber-Surgeons Hall, London *Cancelled*
About HGF Healthcare team

HGF’s Healthcare team provides professional expertise and commercially focused advice to business leaders and decision makers in the healthcare fields of life sciences, pharmaceuticals and medical devices. HGF has in-depth knowledge of the sector, and the experience to provide you with high quality and commercially focused advice in relation to the protection of your IP rights. The team offers the full range of IP services including:

  • IP strategy and advice;
  • Patent and trade mark procurement;
  • IP portfolio management;
  • Freedom-to-operate advice and opinions;
  • IP due diligence assessments and opinions;
  • Supplementary protection certificates and data exclusivity advice;
  • IP licences and agreements;
  • IP disputes management and litigation

For more information on the team please click here.

Please join our Healthcare+IP LinkedIn group which discusses stories and legal developments in the intellectual property field which impacts the healthcare sector.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article